Investigational New Drugs Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Efficacy and Safety of BGG492 as Adjunctive Treatment in Patients With Partial Onset Seizures
Condition: Partial Onset SeizuresInterventions: Drug: Investigational new drug, company code: BGG492; Drug: Placebo; Drug: Investigational new drug, company code: BGG492Sponsors: Novartis; NovartisCompleted - verified February 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 15, 2010 Category: Research Source Type: clinical trials
Treatment Of Primary Generalized Tonic-Clonic Seizures With An Investigational New Drug
Condition: Epilepsy, Tonic-ClonicIntervention: Drug: lamotrigineSponsors: GlaxoSmithKline; GlaxoSmithKlineCompleted - verified August 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2002 Category: Research Source Type: clinical trials
